Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Study Could Help Stroke Victims

25.04.2007
A University of Leicester study could help to provide a new lease of life for patients who have suffered a stroke.

The research published in the American Journal of Hypertension confirms the safety of a drug, Lisinopril, that lowers their blood pressure-without reducing the blood flow to the brain.

Now a larger Leicester trial is under way to investigate the drug’s benefits for victims of strokes.

Dr David Eveson, of the Department of Cardiovascular Sciences at the University of Leicester, said: “High blood pressure is common immediately after a stroke. Stroke patients with high blood pressure tend to have a worse outcome than those with normal blood pressure and therefore it may be helpful to lower blood pressure immediately after stroke.

“However, trials to date have shown variable results, probably because treatment was either started too late or the wrong drug was used.

“The ACE inhibitor class of blood pressure lowering drugs, of which Lisinopril is a member, have been shown in studies to lower blood pressure but preserve the blood flow to the brain which may be all important after stroke. This study compared the use of blood pressure lowering with Lisinopril versus placebo treatment within a few hours of acute stroke in patients presenting to University Hospitals Leicester. The results showed that blood pressure was effectively lowered in the treated group and this did not result in any adverse outcome in comparison with placebo.

“The study was too small to demonstrate any benefit but it did confirm safety and thus a larger Leicester-based trial (CHHIPS) is under way to see if this treatment can be of benefit to patients.”

The study is entirely led by the University of Leicester which is in the forefront of international stroke research.

Dr Eveson added: “Stroke is the second commonest cause of death in the UK and the commonest cause of adult disability. It is imperative that we strive to discover new treatments for stroke to reduce the substantial impact of this disease.

“This study evaluates, for the first time, an established blood pressure lowering drug immediately after stroke and confirms its safety in this group, thereby paving the way for larger studies to discover if it may benefit patients.”

Alex Jelley | alfa
Further information:
http://www.le.ac.uk

More articles from Studies and Analyses:

nachricht First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf

nachricht Do microplastics harbour additional risks by colonization with harmful bacteria?
05.04.2018 | Leibniz-Institut für Ostseeforschung Warnemünde

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Why we need erasable MRI scans

New technology could allow an MRI contrast agent to 'blink off,' helping doctors diagnose disease

Magnetic resonance imaging, or MRI, is a widely used medical tool for taking pictures of the insides of our body. One way to make MRI scans easier to read is...

Im Focus: BAM@Hannover Messe: innovative 3D printing method for space flight

At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.

Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

World's smallest optical implantable biodevice

26.04.2018 | Power and Electrical Engineering

Molecular evolution: How the building blocks of life may form in space

26.04.2018 | Life Sciences

First Li-Fi-product with technology from Fraunhofer HHI launched in Japan

26.04.2018 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>